Cargando…
重组人血小板生成素治疗41例儿童原发免疫性血小板减少症的疗效及安全性
OBJECTIVE: To evaluate the efficacy and safety of recombinant human thrombopoietin (rhTPO) in treatment of pediatric primary immune thrombocytopenia (ITP). METHODS: The clinical characteristics of 41 pediatric ITP patients who received rhTPO therapy from December 2006 to September 2014 were retrospe...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343073/ https://www.ncbi.nlm.nih.gov/pubmed/26134019 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.06.014 |